{"Liposomes": [0, 26], "are": [1, 78], "now": [2], "considered": [3, 57], "the": [4, 52], "most": [5], "commonly": [6], "used": [7], "nanocarriers": [8], "for": [9, 41, 44], "various": [10], "potentially": [11], "active": [12], "hydrophobic": [13], "and": [14, 23, 33, 47, 65, 69, 90, 110], "hydrophilic": [15], "molecules": [16], "due": [17], "to": [18, 29, 58, 67, 82], "their": [19, 39], "high": [20], "biocompatibility,": [21], "biodegradability,": [22], "low": [24], "immunogenicity.": [25], "also": [27], "proved": [28], "enhance": [30], "drug": [31, 75], "solubility": [32], "controlled": [34], "distribution,": [35], "as": [36, 38, 87], "well": [37], "capacity": [40], "surface": [42], "modifications": [43], "targeted,": [45, 64], "prolonged,": [46], "sustained": [48], "release.": [49], "Based": [50], "on": [51], "composition,": [53, 107], "liposomes": [54, 94, 105], "can": [55], "be": [56], "have": [59, 95], "evolved": [60], "from": [61], "conventional,": [62], "long-circulating,": [63], "immune-liposomes": [66], "stimuli-responsive": [68], "actively": [70], "targeted": [71], "liposomes.": [72], "Many": [73], "liposomal-based": [74], "delivery": [76], "systems": [77], "currently": [79], "clinically": [80], "approved": [81], "treat": [83], "several": [84], "diseases,": [85], "such": [86], "cancer,": [88], "fungal": [89], "viral": [91], "infections;": [92], "more": [93], "reached": [96], "advanced": [97], "phases": [98], "in": [99], "clinical": [100, 111], "trials.": [101], "This": [102], "review": [103], "describes": [104], "structure,": [106], "preparation": [108], "methods,": [109], "applications.": [112]}